GGrantIndex
Sort

53,477 grants matching addiction

A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans

$637,310
Kelly E Dunn · Johns Hopkins University · R01 · FY2014 · DA

A DUAL CHIMERIC HUMAN ASTROGLIAL-MICROGLIAL MODEL OF HIV AND HAND

$637,286
Steven A Goldman · University Of Rochester · R01 · FY2024 · DA

Targeting mechanisms contributing to vascular dysfunction and pain in sickle cell disease

$637,263
Kalpna Gupta · University Of California-Irvine · R01 · FY2019 · HL

Regulation of Craving Under Stress: Neural Mechanisms and Novel Model

$637,234
Hedy Kober · Yale University · R01 · FY2021 · DA

Strategies for Improving Prescription Opioid Use in Perioperative Pain Management

$637,144
Marie Hanna · Johns Hopkins University · R01 · FY2021 · CE

Improving health and employment outcomes through workplace opioid policies

$637,127
Ann Marie Dale · Washington University · R34 · FY2019 · DA

Phenotyping and Biobanking Core

$636,999
Duncan B. Clark · University Of Pittsburgh At Pittsburgh · P50 · FY2020 · DA

Alternative payment models and alcohol use disorder treatment and consequences

$636,989
Susan H Busch · Yale University · R01 · FY2022 · AA

Disease Management for Smokers in Rural Primary Care

$636,989
Edward F Ellerbeck · University Of Kansas Medical Center · R01 · FY2006 · CA

Organizational Change and Nicotine Dependence Treatment

$636,934
Joseph R Guydish · University Of California, San Francisco · R01 · FY2006 · DA

Medical Marijuana, Neurocognition, and Subsequent Substance Use

$636,868
Jodi Gilman · Massachusetts General Hospital · R01 · FY2020 · DA

Medical Marijuana, Neurocognition, and Subsequent Substance Use

$636,868
Jodi Gilman · Massachusetts General Hospital · R01 · FY2021 · DA

CTN Membership and Adoption of Innovative Tx Practices

$636,856
Paul M Roman · University Of Georgia · R01 · FY2007 · DA

Developing Chemical Probes for Inflammatory Pain

$636,751
Bahaa Elgendy · St. Louis College Of Pharmacy · R01 · FY2022 · NS

GENETIC DISSECTION OF GLUTAMATE RECEPTOR FUNCTION

$636,629
Salk Institute For Biological Studies · R01 · FY2001 · NS

Optimal TTM Tailoring for Population Cessation

$636,595
Colleen A. Redding · University Of Rhode Island · R01 · FY2010 · DA

Pharmacokinetics and Pharmacodynamics of Nicotine

$636,591
Neal L Benowitz · University Of California, San Francisco · R01 · FY2011 · DA

Adult Progression of Adolescent Onset Substance Use Disorder in a High Risk Sample

$636,588
Christian J Hopfer · University Of Colorado Denver · R01 · FY2025 · DA

Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patient

$636,559
Hermine Poghosyan · Yale University · R01 · FY2022 · CA

Lay Understanding of Race, Addiction and Genetics

$636,509
Alexandra E Shields · Massachusetts General Hospital · R01 · FY2008 · HG

Mindfulness-based Smoking Cessation Enhanced with Mobile Technology for Low-Income Smokers

$636,485
Claire Adams Spears · Georgia State University · R01 · FY2020 · CA

Efficacy of Bupropion for Treating Spit Tobacco Users

$636,482
Mayo Clinic · R01 · FY2004 · CA

Testing Peer-led Network Intervention to Prevent Adolescent Vaping

$636,476
Peter A Wyman · University Of Rochester · R01 · FY2025 · DA

The Cognitive Neuroscience of Female Psychopathy

$636,411
Kent A Kiehl · The Mind Research Network · R01 · FY2010 · MH

In Vivo Screening Strategies

$636,352
Paul J Kenny · Scripps Research Institute, The · P01 · FY2014 · DA